NOA-22 / RIT-GBM NOA-22/RIT-GBM Radioimmunotherapy: Anti-CA12 LU173 Phase I in maintenance therapy (reservoir in the resection cavity) Previous Study NOA-18/Improve-Codel Next Study NOA-24/MecMeth